A laboratory-based analysis of nontuberculous mycobacterial lung disease in Japan from 2012 to 2013

Annals of the American Thoracic Society

Volumn 14, Issue 1, 2017, Pages 49-56

  Morimoto, Kozo ^a   Hasegawa, Naoki ^b   Izumi, Kiyohiko ^c,d   Namkoong, Ho ^b,e   Uchimura, Kazuhiro ^c   Yoshiyama, Takashi ^a   Hoshino, Yoshihiko ^f   Kurashima, Atsuyuki ^a   Sokunaga, Jun ^g   Shibuya, Shunsuke ^h   Shimojima, Masahiro ⁱ   Ato, Manabu ^f   Mitarai, Satoshi ^d,j  

^a Japan Anti tuberculosis Association   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FUKUJUJI HOSPITAL   (Japan)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^e Public Interest Foundation Corporation Life Extension Laboratory Attached Eiju General Hospital   (Japan)

^f NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^g SRL INC   (Japan)

^h LSI MEDIENCE CORPORATION   (Japan)

ⁱ 350 1101   (Japan)

^j RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

more..

Author keywords

Clarithromycin; Epidemiology; Nontuberculous mycobacteriosis; Prevalence; Regional differences

Indexed keywords

CLARITHROMYCIN; TUBERCULOSTATIC AGENT;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ATYPICAL MYCOBACTERIOSIS; FEMALE; HUMAN; INCIDENCE; JAPAN; LABORATORY TEST; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM MARINUM; MYCOBACTERIUM PEREGRINUM; MYCOBACTERIUM SCROFULACEUM; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TERRAE; MYCOBACTERIUM TRIVIALE; MYCOBACTERIUM XENOPEI; PREVALENCE; VERY ELDERLY; AGE DISTRIBUTION; LUNG TUBERCULOSIS; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM KANSASII; SEX RATIO;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CLARITHROMYCIN; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM KANSASII; PREVALENCE; SEX DISTRIBUTION; TUBERCULOSIS, PULMONARY;

EID: 85008392723     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201607-573OC     Document Type: Article

References (31)

1. Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med 2015;36:13-34.
2. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al.; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175: 367-416.
3. Published erratum appears in Am J Respir Crit Care Med 2007;175:744-745.
4. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009;49:e124-e129.
5. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med 2012;185:881-886.
6. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, Saulson A, Hedberg K. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010;182:977-982.
7. Henkle E, Hedberg K, Schafer S, Novosad S, Winthrop KL. Populationbased incidence of pulmonary nontuberculous mycobacterial disease in Oregon 2007 to 2012. Ann Am Thorac Soc 2015;12:642-647.
8. Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, Mitarai S. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis 2016;22:1116-1117.
9. Morimoto K, Iwai K, Uchimura K, Okumura M, Yoshiyama T, Yoshimori K, Ogata H, Kurashima A, Gemma A, Kudoh S. A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan. Ann Am Thorac Soc 2014;11:1-8.
10. Inagaki T, Yagi T, Ichikawa K, Nakagawa T, Moriyama M, Uchiya K, Nikai T, Ogawa K. Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium complex isolates. J Antimicrob Chemother 2011;66:722-729.
11. van Ingen J, Kuijper EJ. Drug susceptibility testing of nontuberculous mycobacteria. Future Microbiol 2014;9:1095-1110.
12. Clinical and Laboratory Standards Institute (CLSI). Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard, 2nd ed., M24-A2 ed. Wayne, PA: CLSI; 2012.
13. Arnow PM, Bakir M, Thompson K, Bova JL. Endemic contamination of clinical specimens by Mycobacterium gordonae. Clin Infect Dis 2000;31:472-476.
14. Morimoto K, Kazumi Y, Shiraishi Y, Yoshiyama T, Murase Y, Ikushima S, Kurashima A, Kudoh S, Goto H, Maeda S. Clinical and microbiological features of definite Mycobacterium gordonae pulmonary disease: the establishment of diagnostic criteria for low-virulence mycobacteria. Trans R Soc Trop Med Hyg 2015; 109:589-593.
15. Maugein J, Dailloux M, Carbonnelle B, Vincent V, Grosset J; French Mycobacteria Study Group. Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease. Eur Respir J 2005;26:1092-1096.
16. Statistics Bureau, Ministry of Internal Affairs and Communications. [National census results] [in Japanese]. Tokyo: Ministry of Internal Affairs and Communications; 2010 [accessed 2015 Oct 16]. Available from: http://www.e-stat.go.jp/SG1/estat/eStatTopPortal.do
17. Saito H, Tomioka H, Sato K, Tasaka H, Tsukamura M, Kuze F, Asano K. Identification and partial characterization of Mycobacterium avium and Mycobacterium intracellulare by using DNA probes. J Clin Microbiol 1989;27:994-997.
18. Han XY, Tarrand JJ, Infante R, Jacobson KL, Truong M. Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS. J Clin Microbiol 2005;43:4407-4412.
19. Wallace RJ Jr, Zhang Y, Brown BA, Dawson D, Murphy DT, Wilson R, Griffith DE. Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med 1998;158:1235-1244.
20. Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, et al.; Nontuberculous Mycobacteria Network European Trials Group. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J 2013;42: 1604-1613.
21. Tsukamura M, Kita N, Shimoide H, Nagasawa S, Mishima Y, Uemura H, Kuze A, Arakawa H, Shinoda A, Matsuura K, et al. Studies on the nontuberculous lung mycobacteriosis in Japan (report of the study year 1985 of the Mycobacteriosis Research Group of the Japanese National Chest Hospitals): incidence rate of lung disease caused by Mycobacterium kansasii is still increasing which elevates the incidence rate of nontuberculous lung mycobacteriosis [in Japanese]. Kekkaku 1987;62:319-327.
22. Simons S, van Ingen J, Hsueh PR, Van Hung N, Dekhuijzen PN, Boeree MJ, van Soolingen D. Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis 2011;17:343-349.
23. Jeon K, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH, Park YK, Kim CK, Koh WJ. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med 2009;180:896-902.
24. Chien JY, Lai CC, Sheng WH, Yu CJ, Hsueh PR. Pulmonary infection and colonization with nontuberculous mycobacteria, Taiwan, 2000-2012. Emerg Infect Dis 2014;20:1382-1385.
25. Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012;185:575-583.
26. Tsukamura M, Shimoide H, Kita N, Segawa J, Ito T. A study on the frequency of 'atypical' Mycobacteria and of 'atypical' mycobacterioses in Japanese National Chest Hospitals (report of the year 1971-1972) [in Japanese]. Kekkaku 1973;48:203-211.
27. van Ingen J, Bendien SA, de Lange WC, Hoefsloot W, Dekhuijzen PN, Boeree MJ, van Soolingen D. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax 2009;64:502-506.
28. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, Bai GH. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006;129:341-348.
29. Al Houqani M, Jamieson F, Chedore P, Mehta M, May K, Marras TK. Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario in 2007. Can Respir J 2011;18:19-24.
30. van Ingen J, Wagner D, Gallgher J, Morimoto K, Lange C, Haworth CS, Floto RA, Adjemian J, Prevots DR, Griffith DE for the NTM-NET. Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases. Eur Respir J 2016 (In press)
31. Jankovic M, Sabol I, Zmak L, Jankovic VK, Jakopovic M, Obrovac M, Ticac B, Bulat LK, Grle SP, Marekovic I, et al. Microbiological criteria in non-tuberculous mycobacteria pulmonary disease: a tool for diagnosis and epidemiology. Int J Tuberc Lung Dis 2016;20: 934-940.